162 related articles for article (PubMed ID: 22427025)
1. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
Li P; Zhang D; Guo C
Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
[TBL] [Abstract][Full Text] [Related]
2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Lim JY; Cho JY; Paik YH; Chang YS; Kim HG
Int J Biol Markers; 2007; 22(4):281-6. PubMed ID: 18161659
[TBL] [Abstract][Full Text] [Related]
4. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
5. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
6. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
7. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
9. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
10. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
12. Screening of serum protein biomarkers in hemorrhagic cerebral infarction by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology.
Han Z; Wen L; Feng L
Ann Transl Med; 2020 Sep; 8(18):1186. PubMed ID: 33241035
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
15. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
[TBL] [Abstract][Full Text] [Related]
16. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
17. [Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma].
Xia T; Zheng ZG; Gao Y; Mou HZ; Xu SH; Zhang P; Zhu JQ
Ai Zheng; 2008 Mar; 27(3):279-82. PubMed ID: 18334117
[TBL] [Abstract][Full Text] [Related]
18. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
19. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
20. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]